Literature DB >> 7554386

Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL.

R Wu1, A K Lefvert.   

Abstract

Circulating antibodies against oxLDL are present in several inflammatory and autoimmune conditions. Such antibodies are also present in patients with atherosclerosis, although the pathogenic significance of the antibodies is still not known. We have characterized the antibodies with regard to isotype, subclass, affinity and effect on macrophage uptake of oxLDL. Antibodies of IgG and IgM isotype were most common and found both in patients with atherosclerosis and in normal individuals. The subclass of IgG antibodies was mainly IgG2 and IgG3. Scatchard analyses of IgG and IgM antibodies showed that IgG antibodies were heterogeneous with regard to affinity, whereas only one population of high-affinity antibodies was found in the IgM antibody population. The high-affinity populations had an average equilibrium constant (K0) of 8.84 x 10(9) M-1 for IgG antibodies and of 1.65 x 10(9) M-1 for IgM antibodies. Incubation of 125I-oxLDL with purified IgG and IgM from sera with high amounts of antibodies enhanced the uptake of 125I-oxLDL in the monocyte-like U937 cell line. Antibody preparations from sera containing no anti-oxLDL antibodies and from sera with antibodies against LDL had less effect on this uptake. The increased uptake was competitively decreased by adding unlabelled oxLDL. This study shows that antibodies against oxLDL are mainly IgG2, IgG3 and IgM. Both IgG and IgM antibodies have a high affinity for the antigen and increase the uptake of oxLDL in a monocyte-like cell line.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554386      PMCID: PMC1553342          DOI: 10.1111/j.1365-2249.1995.tb06652.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates.

Authors:  J C Khoo; E Miller; F Pio; D Steinberg; J L Witztum
Journal:  Arterioscler Thromb       Date:  1992-11

Review 2.  Role of oxidatively modified LDL in atherosclerosis.

Authors:  U P Steinbrecher; H F Zhang; M Lougheed
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

3.  IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.

Authors:  B Vandvik; J B Natvig; E Norrby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

4.  Evaluation of the quantity and affinity of human IgG "blocking" antibodies.

Authors:  N F Adkinson; A K Sobotka; L M Lichtenstein
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

5.  Lipoprotein fractionation.

Authors:  K Carlson
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

6.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

7.  Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein.

Authors:  D W Branch; M D Mitchell; E Miller; W Palinski; J L Witztum
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321

8.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.

Authors:  S Ylä-Herttuala; W Palinski; S W Butler; S Picard; D Steinberg; J L Witztum
Journal:  Arterioscler Thromb       Date:  1994-01

9.  Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.

Authors:  M F Lopes-Virella; R L Griffith; K A Shunk; G T Virella
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

10.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.

Authors:  D V Parums; D L Brown; M J Mitchinson
Journal:  Arch Pathol Lab Med       Date:  1990-04       Impact factor: 5.534

View more
  20 in total

Review 1.  Lipoprotein autoantibodies: measurement and significance.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.

Authors:  E Ahmed; S Nityanand; A Mustafa; K Brismar; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Letiane Machado; Maria Marta Medeiros Frescura Duarte; Débora Guerini Souza; Priscila Machado; Adriano Martimbianco de Assis; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2016-01-11       Impact factor: 5.614

4.  High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis.

Authors:  D J Grainger; H W L Bethell
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

5.  Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.

Authors:  Shang-Hung Chang; Michael Johns; Joseph J Boyle; Ellen McConnell; Paul A Kirkham; Colin Bicknell; M Zahoor-ul-Hassan Dogar; Robert J Edwards; Oliver Gale-Grant; Ramzi Khamis; Kurrun V V Ramkhelawon; Dorian O Haskard
Journal:  Hybridoma (Larchmt)       Date:  2012-04

6.  Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.

Authors:  R Wu; E Svenungsson; I Gunnarsson; C Haegerstrand-Gillis; B Andersson; I Lundberg; L S Elinder; J Frostegård
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers.

Authors:  Maria Gabriela Valle Gottlieb; Ivana Beatrice Mânica da Cruz; Marta M F Duarte; Rafael Noal Moresco; Mário Wiehe; Carla Helena Augustin Schwanke; Luiz Carlos Bodanese
Journal:  J Clin Endocrinol Metab       Date:  2009-12-16       Impact factor: 5.958

Review 8.  Clinical significance of the humoral immune response to modified LDL.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Clin Immunol       Date:  2009-05-08       Impact factor: 3.969

Review 9.  Cardiorheumatology: cardiac involvement in systemic rheumatic disease.

Authors:  Megha Prasad; Joerg Hermann; Sherine E Gabriel; Cornelia M Weyand; Sharon Mulvagh; Rekha Mankad; Jae K Oh; Eric L Matteson; Amir Lerman
Journal:  Nat Rev Cardiol       Date:  2014-12-23       Impact factor: 32.419

10.  Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.

Authors:  Carlos Borelli Zeller; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.